News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Immunicon Corporation (IMMC) Announces Availability of Fluorescence In-Situ Hybridization Product Portfolio



4/8/2008 8:56:41 AM

HUNTINGDON VALLEY, Pa.--(BUSINESS WIRE)--Immunicon Corporation (NASDAQ:IMMC) announced today the availability of a new product portfolio for Fluorescence In-Situ Hybridization (FISH) testing. The new RF Poseidon™ FISH Probes are available to the life science and diagnostic clinical laboratories.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES